The benefit of salvage chemotherapy in gastric cancer refractory to first-line platinum and fluoropyrimidine therapy was previously unknown. A randomised multicentre study has shown that irinotecan or docetaxel administered as single agents improved survival compared [more]
A qualitative study indicates that there is a positive selection bias towards favourable economic analysis of targeted therapies when these are funded by the manufacturer. At a time of increasing budgetary constraints and public scrutiny [more]
To mark 30 years of helping to improve the quality of care provided to cancer patients, ESO is convening a jury of 100 experts at the World Oncology Forum in Lugano this October to examine [more]
Austerity measures brought in to tackle the debt crisis are affecting frontline healthcare services in many countries, particularly in the complex, expensive field of oncology. Cancer World asked readers to share their first-hand experiences. Doctors [more]
Implement guidelines, adopt what works and reject what doesn’t, focus on cost-effectiveness–there are so many ways cancer care could be improved. Mary Gospodarowicz, believer, pragmatist and ‘raving optimist’, is determined to make it happen. Implement [more]
Too toxic, too untargeted, too difficult to prove. These assumptions about chemoprevention are being challenged by important developments in the search for preventive options tailored to specific risk factors in breast cancer. Recent years have [more]
Often mistaken for a radiotherapist or medical oncologist, this expert in voice-box sparing strategies has reached out to a wide variety of professionals– most recently actors– in his quest to improve the chances of patients [more]
Cancer patients who do not share their doctors’ belief in the drug they are prescribed, or find living with the side-effects hard to bear, may fail to take their pills according to the prescription– and [more]